{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:58:46Z","timestamp":1790099926509,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.nano.2022.102640","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T20:18:09Z","timestamp":1671481089000},"page":"102640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Neutrophil membrane-coated nanoparticles exhibit increased antimicrobial activities in an anti-microbial resistant K. pneumonia infection model"],"prefix":"10.1016","volume":"48","author":[{"given":"Jun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.nano.2022.102640_bb0005","doi-asserted-by":"crossref","first-page":"16162","DOI":"10.1038\/nmicrobiol.2016.162","article-title":"Combating multidrug-resistant gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers","volume":"1","author":"Lam","year":"2016","journal-title":"Nat Microbiol"},{"issue":"7","key":"10.1016\/j.nano.2022.102640_bb0010","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/resp.13115","article-title":"The respiratory threat posed by multidrug resistant Gram-negative bacteria","volume":"22","author":"Rodrigo-Troyano","year":"2017","journal-title":"Respirology"},{"issue":"3","key":"10.1016\/j.nano.2022.102640_bb0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijantimicag.2012.04.020","article-title":"Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection","volume":"40","author":"Lopes","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.nano.2022.102640_bb0020","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2018.04.040","article-title":"Clearance of intracellular Klebsiella pneumoniae infection using gentamicin-loaded nanoparticles","volume":"279","author":"Jiang","year":"2018","journal-title":"J Control Release"},{"issue":"11","key":"10.1016\/j.nano.2022.102640_bb0025","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/cmi.12466","article-title":"Klebsiella pneumoniae survives within macrophages by avoiding delivery to lysosomes","volume":"17","author":"Cano","year":"2015","journal-title":"Cell Microbiol"},{"issue":"5","key":"10.1016\/j.nano.2022.102640_bb0030","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijantimicag.2005.01.018","article-title":"The effect of surface charge on the disposition of liposome-encapsulated gentamicin to the rat liver, brain, lungs and kidneys after intraperitoneal administration","volume":"25","author":"Abraham","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1016\/j.nano.2022.102640_bb0035","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1128\/AAC.45.11.2977-2986.2001","article-title":"Use of aminoglycosides in treatment of infections due to intracellular bacteria","volume":"45","author":"Maurin","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.nano.2022.102640_bb0040","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fchem.2018.00360","article-title":"Nanomedicine: principles, properties, and regulatory issues","volume":"6","author":"Soares","year":"2018","journal-title":"Front Chem"},{"issue":"4","key":"10.1016\/j.nano.2022.102640_bb0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4155\/tde-2017-0118","article-title":"Nanomedicine: is it lost in translation?","volume":"9","author":"Greish","year":"2018","journal-title":"Ther Deliv"},{"issue":"30","key":"10.1016\/j.nano.2022.102640_bb0050","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.2174\/1568026619666181224104838","article-title":"Nanomedicine for cancer therapy using autophagy: an overview","volume":"18","author":"Kotcherlakota","year":"2018","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"10.1016\/j.nano.2022.102640_bb0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/acsnano.6b08244","article-title":"Mechanisms and barriers in cancer nanomedicine: addressing challenges,looking for solutions","volume":"11","author":"Anchordoquy","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2022.102640_bb0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nantod.2017.06.010","article-title":"Design of nanocarriers based on complex biological barriers in vivo for tumor therapy","volume":"15","author":"Liu","year":"2017","journal-title":"Nano Today"},{"issue":"9","key":"10.1016\/j.nano.2022.102640_bb0065","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.nano.2022.102640_bb0070","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/s41467-020-16439-7","article-title":"Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines","volume":"11","author":"Gao","year":"2020","journal-title":"Nat Commun"},{"issue":"16","key":"10.1016\/j.nano.2022.102640_bb0075","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.2217\/nnm-2018-0017","article-title":"The potential of biomimetic nanoparticles for tumor-targeted drug delivery","volume":"13","author":"Li","year":"2018","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"10.1016\/j.nano.2022.102640_bb0080","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/14686996.2018.1528850","article-title":"Functional biomimetic nanoparticles for drug delivery and theranostic applications in cancer treatment","volume":"19","author":"Li","year":"2018","journal-title":"Sci Technol Adv Mater"},{"issue":"23","key":"10.1016\/j.nano.2022.102640_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Adv Mater"},{"issue":"4","key":"10.1016\/j.nano.2022.102640_bb0090","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1021\/acs.bioconjchem.8b00103","article-title":"Recent advances of membrane-cloaked nanoplatforms for biomedical applications","volume":"29","author":"Ai","year":"2018","journal-title":"Bioconjug Chem"},{"issue":"2","key":"10.1016\/j.nano.2022.102640_bb0095","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/cbdd.13323","article-title":"Co-administration of kla-TAT peptide and iRGD to enhance the permeability on A549 3D multiple sphere cells and accumulation on xenograft mice","volume":"92","author":"Hu","year":"2018","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.nano.2022.102640_bb0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.actbio.2015.07.029","article-title":"Blood compatibility of magnesium and its alloys","volume":"25","author":"Feyerabend","year":"2015","journal-title":"Acta Biomater"},{"issue":"12","key":"10.1016\/j.nano.2022.102640_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202006484","article-title":"Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy","volume":"17","author":"Oroojalian","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.nano.2022.102640_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107624","article-title":"Biodegradable hypocrellin B nanoparticles coated with neutrophil membranes for hepatocellular carcinoma photodynamics therapy effectively via JUNB\/ROS signaling","volume":"99","author":"Zhang","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"10.1016\/j.nano.2022.102640_bb0115","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41565-018-0254-4","article-title":"Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis","volume":"13","author":"Zhang","year":"2018","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"10.1016\/j.nano.2022.102640_bb0120","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1038\/s41598-018-21387-w","article-title":"Red blood cells are dynamic reservoirs of cytokines","volume":"8","author":"Karsten","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.nano.2022.102640_bb0125","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","article-title":"Quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors","volume":"12","author":"Dai","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2022.102640_bb0130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.matbio.2015.04.004","article-title":"Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature","volume":"44\u201346","author":"Deryugina","year":"2015","journal-title":"Matrix Biol"},{"key":"10.1016\/j.nano.2022.102640_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.772522","article-title":"Research progress on cell membrane-coated biomimetic delivery systems","volume":"9","author":"Guo","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"issue":"4","key":"10.1016\/j.nano.2022.102640_bb0140","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ijantimicag.2012.12.009","article-title":"Galleria mellonella as a model system to test the pharmacokinetics and efficacy of antibiotics against Burkholderia pseudomallei","volume":"41","author":"Thomas","year":"2013","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.nano.2022.102640_bb0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1462-5822.2011.01707.x","article-title":"Inflammasome activation via intracellular NLRs triggered by bacterial infection","volume":"14","author":"Koizumi","year":"2012","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.nano.2022.102640_bb0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12989-016-0129-5","article-title":"Extracellular cathepsin S and intracellular caspase 1 activation are surrogate biomarkers of particulate-induced lysosomal disruption in macrophages","volume":"13","author":"Hughes","year":"2016","journal-title":"Part Fibre Toxicol"},{"issue":"12","key":"10.1016\/j.nano.2022.102640_bb0155","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/ni.1960","article-title":"Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria","volume":"11","author":"Miao","year":"2010","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.nano.2022.102640_bb0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri.2016.147","article-title":"Programmed cell death as a defence against infection","volume":"17","author":"Jorgensen","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"10.1016\/j.nano.2022.102640_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080881","article-title":"Size dependency of circulation and biodistribution of biomimetic nanoparticles: red blood cell membrane-coated nanoparticles","volume":"8","author":"Li","year":"2019","journal-title":"Cells"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963422001265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963422001265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:21:12Z","timestamp":1761549672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963422001265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":33,"alternative-id":["S1549963422001265"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2022.102640","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophil membrane-coated nanoparticles exhibit increased antimicrobial activities in an anti-microbial resistant K. pneumonia infection model","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2022.102640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102640"}}